Emergency Medicine Doctors in Bridgeport, WV Accepting Medicare

10 Emergency Medicine doctors found. Showing 1 - 10

Harry Marinakis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 49 E Wexford Way, Bridgeport, WV 26330 Phone: 304-669-6720

Justine A Pagenhardt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000

Dr. Dale Mcmillion, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 304-293-2436

Dr. Stuart Patterson Godwin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 304-293-2436    Fax: 304-285-7126

Dr. Robert Lehki, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000

Jessica Neidhardt, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000

Dr. Timothy M Peasak, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1370 Johnson Ave, 1st Floor, Bridgeport, WV 26330 Phone: 304-842-3330    Fax: 304-842-3303

Christopher Patrick Conrad, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1932

Dr. Nicholas Michael Chill, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000

Courtney Anne Cundiff, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000

News Archive

Gothenburg researcher advises patients with acute low back pain to stay active

Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.

Schering-Plough acquires Organon BioSciences

Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.

U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci

Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.

New IOM report calls for campaign to promote public education on CPR and AED use

A new report released today from the Institute of Medicine calls for a campaign to promote public education and training opportunities to reduce barriers to the provision of bystander CPR and defibrillation.

New study shows large within- and between-assay variation for ß-CTX measurement

A new study by the IFCC‑IOF Committee for Bone Metabolism shows large within- and between-assay variation for ß-CTX measurement; until harmonization is achieved, proposes measuring ß-CTX by the same assay on EDTA plasma, especially for research.

Read more Medical News

› Verified 3 days ago